Navigation Links
Composite fillings to hasten work procedures

Amorphous calcium phosphate is showing great covenant in dental restorative work, say researchers at the National Institute of Standards and Technology at Ohio.//This ACP has new physical-chemical properties,” says Tyndall Don, Ph.D., a researcher at OSU. “It’s more soluble than other calcium phosphates and has a tendency to convert to the stable dental mineral hydroxyapatite, which is the main inorganic component of teeth.”

The product is biocompatible and has remineralization potential, he explains. Simply put, it re-deposits the hydroxyapatite in areas of the tooth damaged by decay — caries — helping the tooth structure to repair itself.ACP has been around for decades, but this new compound has the unique ability to incorporate with photocurable polymer composite resins — making it stable or degradable, depending on your intended application.

The most proximate application of nonbiodegradable ACP would be in orthodontics. Mixing it into the adhesive would prevent cavities from forming around the orthodontic brace via remineralization, or at least would inhibit demineralization.

Another use is as a base material, or liner, underneath the regular filling. This would stop secondary cavities from forming around the original cavity under or adjacent to the filling. Dr. Don calls this a major advancement since more than half of fillings are necessitated by secondary tooth decay.

“Compared with conventional composites, the ACP is weaker mechanically and cannot be used for major restorations,” says Dr. Don. “We are working on improvement of mechanical properties by modifying the surface properties of ACP and by changing the composition of the resin," he says.br>

'"/>




Page: 1

Related medicine news :

1. Mercury fillings during pregnancy may not lead to low birth weight
2. Thyroid hormone treatment hastens recovery after cardiac surgery
3. Chronic binge drinking can hasten HIV development
4. Benefits in fertility procedures
5. Survival rate not improved by invasive procedures
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: